Response Genetics Stock Price (OTCMKTS:RGDXQ)

Add to My Stocks
$0 $0 (0%) RGDXQ stock closing price Mar 27, 2017 (Closing)
Prev Close* : $0.00
Market Cap:
$0.03M
Day Low: $0
52 Week Low: N/A
Open: $0
Volume: 9672
Day High: $0
52 Week High: $0.01
Dividend:
N/A

Latest Stock Market News

Latest Articles

Response Genetics News - From Partners

RGDXQ Stockcharts

View RGDXQ PE ratio, PS ratio stocks charts and compare with peers.
RGDXQ Chart
Note: Compare Response Genetics stock price history with the index and industry peers.

RGDXQ Industry Peers

Company Price Change (%)
Scolr Pharma (SCLR)00 (0%)
Akesis Pharma (AKESQ)00 (0%)
Vermillion (VRML)2.220.08 (3.74%)
Foundation Medicine (FMI)34.051.15 (3.5%)
Rosetta Genomics (ROSG)3.190.03 (0.93%)
Orasure (OSUR)12.490.36 (2.97%)
Alere (ALR)39.030.1 (0.26%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ZIOPHARM Oncology (ZIOP)6.690.81 (13.78%)
Intra-Cellular Therapies (ITCI)16.21.44 (9.76%)
Paratek Pharma (PRTK)17.31.45 (9.15%)
EXACT Sciences (EXAS)22.991.91 (9.06%)
Cara Therapeutics (CARA)18.151.39 (8.29%)
Geron (GERN)2.270.15 (7.08%)
Bluebird Bio (BLUE)94.055.95 (6.75%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 28, 2017
CompanyPriceChange (%)
MannKind (MNKD)1.820.07 (3.7%)
Kamada (KMDA)6.70.2 (2.9%)
Clovis Oncology (CLVS)68.312.01 (2.86%)
Curis (CRIS)2.880.08 (2.7%)
BioTechne Corporation (TECH)101.022.8 (2.7%)
Puma Biotech (PBYI)38.90.8 (2.02%)
Pluristem Therapeutics (PSTI)1.190.02 (1.65%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 28, 2017

Response Genetics Financial Statements

income statement20142013201220112010
Net Sales Or Revenues16.72M19.8M18.73M22.64M21.27M
Net Income-13.69M-8.02M-7.75M-5.7M-4.67M
Total Operating Expense19.7M17.28M15.96M16.58M15.67M
view Response Genetics, Inc. income statement
balance sheet20142013201220112010
Total Assets13.44M18.05M16.58M7.85M10.6M
Total Liabilities14.61M12.29M5.35M6.13M6.02M
Shareholders Equity-1.17M5.75M11.23M1.71M4.58M
view Response Genetics, Inc. balance sheet
cash flow statement20142013201220112010
Net Increase (Decrease) In Assets Liabilities-8.19M-2.74M-2.89M-1.94M-3.56M
Net Cash From (Used By) Operating Activities-14.3M-6.48M-8.01M-5.08M-6.49M
Increase (Decrease) In Prop Plant And Equipment-0.04M-0.62M-0.42M-0.39M-0.39M
view Response Genetics, Inc. cashflow statement

Response Genetics Stock Message Board

As of last trading day, Response Genetics stock price was 0. The total market value as denoted by 0.03M for Response Genetics, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Response Genetics valuation, even though in the short-term sentiment and current breaking news might affect Response Genetics stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Response Genetics is worth a lot, it will most likely be reflected in an inflated Response Genetics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 9672 on the last trading day, as is evident from Response Genetics stock chart, and RGDXQ stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Response Genetics stock price history, gives the entire historical data for RGDXQ stock.